{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:59:52Z","timestamp":1792155592460,"version":"4.4.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Sichuan Science and Technology Program","award":["2023NSFSC0620"],"award-info":[{"award-number":["2023NSFSC0620"]}]},{"name":"the Luzhou Municipal People\u2019s Government-Southwest Medical University Joint Scientific Research Project","award":["2023LZXNYDHZ003, 2023LZXNYDJ004"],"award-info":[{"award-number":["2023LZXNYDHZ003, 2023LZXNYDJ004"]}]},{"name":"the Youth Science Foundation Project of Southwest Medical University","award":["2023QN075"],"award-info":[{"award-number":["2023QN075"]}]},{"name":"the Southwest Medical University Science and Technology Project","award":["2021ZKMS034"],"award-info":[{"award-number":["2021ZKMS034"]}]},{"name":"the College student innovation and entrepreneurship program","award":["202310632027"],"award-info":[{"award-number":["202310632027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s13346-025-01791-2","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T16:32:18Z","timestamp":1738168338000},"page":"2924-2940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["pH-sensitive nano-drug delivery systems dual-target endothelial cells and macrophages for enhanced treatment of atherosclerosis"],"prefix":"10.1007","volume":"15","author":[{"given":"Yiping","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"1791_CR1","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bj\u00f6rkegren","year":"2022","unstructured":"Bj\u00f6rkegren JLM, Lusis AJ. Atherosclerosis. Recent developments. Cell. 2022;185:1630\u201345. https:\/\/doi.org\/10.1016\/j.cell.2022.04.004.","journal-title":"Cell"},{"key":"1791_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cytogfr.2015.04.003","volume":"26","author":"DP Ramji","year":"2015","unstructured":"Ramji DP, Davies TS. Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets. Cytokine Growth Factor Rev. 2015;26:673\u201385. https:\/\/doi.org\/10.1016\/j.cytogfr.2015.04.003.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1791_CR3","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/01.Asn.0000132474.50966.Da","volume":"15","author":"DH Endemann","year":"2004","unstructured":"Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrology: JASN. 2004;15:1983. https:\/\/doi.org\/10.1097\/01.Asn.0000132474.50966.Da.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"1791_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/circresaha118313591","volume":"124","author":"D Wolf","year":"2019","unstructured":"Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circul Res. 2019;124:315\u201327. https:\/\/doi.org\/10.1161\/circresaha118313591.","journal-title":"Circul Res"},{"key":"1791_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature. 2021;592:524\u201333. https:\/\/doi.org\/10.1038\/s41586-021-03392-8.","journal-title":"Nature"},{"key":"1791_CR6","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European atherosclerosis society consensus panel. Eur Heart J. 2020;41:2313\u201330. https:\/\/doi.org\/10.1093\/eurheartj\/ehz962.","journal-title":"Eur Heart J"},{"key":"1791_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/s2213-8587(19)30388-2","volume":"8","author":"N Wang","year":"2020","unstructured":"Wang N, Fulcher J, Abeysuriya N, Park L, Kumar S, Di Tanna GL, et al. Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants. The lancet Diab Endocrinol. 2020;8:36\u201349. https:\/\/doi.org\/10.1016\/s2213-8587(19)30388-2.","journal-title":"The lancet Diab Endocrinol"},{"key":"1791_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cells11244072","author":"Z Guo","year":"2022","unstructured":"Guo Z, Wang L, Liu H, Xie Y. Innate immune memory in monocytes and macrophages: the potential therapeutic strategies for atherosclerosis. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11244072.","journal-title":"Cells"},{"key":"1791_CR9","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1161\/atvbaha.119.312434","volume":"39","author":"Y Wang","year":"2019","unstructured":"Wang Y, Dubland JA, Allahverdian S, Asonye E, Sahin B, Jaw JE, et al. Smooth muscle cells contribute the majority of foam cells in ApoE (apolipoprotein E)-deficient mouse atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. 2019;39:876\u201387. https:\/\/doi.org\/10.1161\/atvbaha.119.312434.","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"1791_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.imbio.2014.05.002","volume":"219","author":"DY Vogel","year":"2014","unstructured":"Vogel DY, Glim JE, Stavenuiter AW, Breur M, Heijnen P, Amor S, et al. Human macrophage polarization in vitro: maturation and activation methods compared. Immunobiology. 2014;219:695\u2013703. https:\/\/doi.org\/10.1016\/j.imbio.2014.05.002.","journal-title":"Immunobiology"},{"key":"1791_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/10409238.2021.1925217","volume":"56","author":"AG Groenen","year":"2021","unstructured":"Groenen AG, Halmos B, Tall AR, Westerterp M. Cholesterol efflux pathways, inflammation, and atherosclerosis. Crit Rev Biochem Mol Biol. 2021;56:426\u201339. https:\/\/doi.org\/10.1080\/10409238.2021.1925217.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"1791_CR12","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/j.redox.2020.101775","volume":"38","author":"M Zhang","year":"2021","unstructured":"Zhang M, Gao J, Zhao X, Zhao M, Ma D, Zhang X, et al. p38\u03b1 in macrophages aggravates arterial endothelium injury by releasing IL-6 through phosphorylating megakaryocytic leukemia 1. Redox Biol. 2021;38:101775. https:\/\/doi.org\/10.1016\/j.redox.2020.101775.","journal-title":"Redox Biol"},{"key":"1791_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/cr.2008.326","volume":"19","author":"MJ Goumans","year":"2009","unstructured":"Goumans MJ, Liu Z, ten Dijke P. TGF-beta signaling in vascular biology and dysfunction. Cell Res. 2009;19:116\u201327. https:\/\/doi.org\/10.1038\/cr.2008.326.","journal-title":"Cell Res"},{"key":"1791_CR14","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","volume":"60","author":"F Tacke","year":"2014","unstructured":"Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol. 2014;60:1090. https:\/\/doi.org\/10.1016\/j.jhep.2013.12.025.","journal-title":"J Hepatol"},{"key":"1791_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/nejm199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R. Atherosclerosis\u2013an inflammatory disease. New England Journal Medi. 1999;340:115\u201326. https:\/\/doi.org\/10.1056\/nejm199901143400207.","journal-title":"New England Journal Medi"},{"key":"1791_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/00071668.2020.1847251","volume":"62","author":"M Zou","year":"2021","unstructured":"Zou M, Yang L, Niu L, Zhao Y, Sun Y, Fu Y, et al. Baicalin ameliorates mycoplasma gallisepticum-induced lung inflammation in chicken by inhibiting TLR6-mediated NF-\u03baB signalling. Br Poult Sci. 2021;62:199\u2013210. https:\/\/doi.org\/10.1080\/00071668.2020.1847251.","journal-title":"Br Poult Sci"},{"key":"1791_CR17","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/jth.13666","volume":"15","author":"CP Molloy","year":"2017","unstructured":"Molloy CP, Yao Y, Kammoun H, Bonnard T, Hoefer T, Alt K, et al. Shear-sensitive nanocapsule drug release for site-specific inhibition of occlusive thrombus formation. J Thromb Haemostasis: JTH. 2017;15:972\u201382. https:\/\/doi.org\/10.1111\/jth.13666.","journal-title":"J Thromb Haemostasis: JTH"},{"key":"1791_CR18","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1021\/jf0352879","volume":"52","author":"K Aaby","year":"2004","unstructured":"Aaby K, Hvattum E, Skrede G. Analysis of flavonoids and other phenolic compounds using high-performance liquid chromatography with coulometric array detection: relationship to antioxidant activity. J Agric Food Chem. 2004;52:4595\u2013603. https:\/\/doi.org\/10.1021\/jf0352879.","journal-title":"J Agric Food Chem"},{"key":"1791_CR19","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.2147\/ijnS213831","volume":"14","author":"YD Taghipour","year":"2019","unstructured":"Taghipour YD, Hajialyani M, Naseri R, Hesari M, Mohammadi P, Stefanucci A, et al. Nanoformulations of natural products for management of metabolic syndrome. Int J Nanomed. 2019;14:5303\u201321. https:\/\/doi.org\/10.2147\/ijnS213831.","journal-title":"Int J Nanomed"},{"key":"1791_CR20","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1039\/d1tb00330e","volume":"9","author":"AP Rumanti","year":"2021","unstructured":"Rumanti AP, Maruf A, Liu H, Ge S, Lei D, Wang G. Engineered bioresponsive nanotherapeutics: recent advances in the treatment of atherosclerosis and ischemic-related disease. J Mater Chem B. 2021;9:4804\u201325. https:\/\/doi.org\/10.1039\/d1tb00330e.","journal-title":"J Mater Chem B"},{"key":"1791_CR21","doi-asserted-by":"publisher","first-page":"120677","DOI":"10.1016\/j.biomaterials.2021.120677","volume":"269","author":"LM Pham","year":"2021","unstructured":"Pham LM, Kim EC, Ou W, Phung CD, Nguyen TT, Pham TT, et al. Targeting and clearance of senescent foamy macrophages and senescent endothelial cells by antibody-functionalized mesoporous silica nanoparticles for alleviating aorta atherosclerosis. Biomaterials. 2021;269: 120677. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120677.","journal-title":"Biomaterials"},{"key":"1791_CR22","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1039\/B922651F","volume":"20","author":"M Manzano","year":"2010","unstructured":"Manzano M, Vallet-Reg\u00ed M. New developments in ordered mesoporous materials for drug delivery. J Mater Chem. 2010;20:5593\u2013604. https:\/\/doi.org\/10.1039\/B922651F.","journal-title":"J Mater Chem"},{"key":"1791_CR23","doi-asserted-by":"publisher","first-page":"8002","DOI":"10.1016\/jbiomaterials201405081","volume":"35","author":"L Liu","year":"2014","unstructured":"Liu L, He H, Zhang M, Zhang S, Zhang W, Liu J. Hyaluronic acid-decorated reconstituted high density lipoprotein targeting atherosclerotic lesions. Biomaterials. 2014;35:8002\u201314. https:\/\/doi.org\/10.1016\/jbiomaterials201405081.","journal-title":"Biomaterials"},{"key":"1791_CR24","doi-asserted-by":"publisher","first-page":"14555","DOI":"10.1021\/acsnano3c01420","volume":"17","author":"H He","year":"2023","unstructured":"He H, Han Q, Wang S, Long M, Zhang M, Li Y, et al. Design of a multifunctional nanozyme for resolving the proinflammatory plaque microenvironment and attenuating atherosclerosis. ACS Nano. 2023;17:14555\u201371. https:\/\/doi.org\/10.1021\/acsnano3c01420.","journal-title":"ACS Nano"},{"key":"1791_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1021\/acsnano.7b07720","volume":"12","author":"X Wei","year":"2018","unstructured":"Wei X, Ying M, Dehaini D, Su Y, Kroll AV, Zhou J, et al. Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis. ACS Nano. 2018;12:109\u201316. https:\/\/doi.org\/10.1021\/acsnano.7b07720.","journal-title":"ACS Nano"},{"key":"1791_CR26","doi-asserted-by":"publisher","first-page":"7663","DOI":"10.1021\/acsnano8b01249","volume":"12","author":"Z Jia","year":"2018","unstructured":"Jia Z, Wang X, Wei X, Zhao G, Foster KW, Qiu F, et al. Micelle-forming dexamethasone prodrug attenuates nephritis in lupus-prone mice without apparent glucocorticoid side effects. ACS Nano. 2018;12:7663\u201381. https:\/\/doi.org\/10.1021\/acsnano8b01249.","journal-title":"ACS Nano"},{"key":"1791_CR27","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jconrel.2022.11.005","volume":"352","author":"X Qin","year":"2022","unstructured":"Qin X, Pan L, Chen T, Li D, Lin X, Li G, et al. Inflammation-responsive nanoparticles suppress lymphatic clearance for prolonged arthritis therapy. J Control Release: Off J Control Release Soc. 2022;352:700\u201311. https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.005.","journal-title":"J Control Release: Off J Control Release Soc"},{"key":"1791_CR28","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1021\/acsmolpharmaceut1c00567","volume":"18","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Xu X, Jiang H, Foster KW, Jia Z, Wei X, et al. Preclinical dose-escalation study of ZSJ-0228, a polymeric dexamethasone prodrug, in the treatment of murine lupus nephritis. Mol Pharm. 2021;18:4188\u201397. https:\/\/doi.org\/10.1021\/acsmolpharmaceut1c00567.","journal-title":"Mol Pharm"},{"key":"1791_CR29","doi-asserted-by":"publisher","first-page":"e2306457","DOI":"10.1002\/smll202306457","volume":"20","author":"Z Chen","year":"2024","unstructured":"Chen Z, Zhu Q, Li D, Lv Q, Fu G, Ma B, et al. Targeting nanoplatform for atherosclerosis inhibition and degradation via a dual-track reverse cholesterol transport strategy. Small (Weinheim an Der Bergstrasse. 2024;20:e2306457. https:\/\/doi.org\/10.1002\/smll202306457.","journal-title":"Small (Weinheim an Der Bergstrasse"},{"key":"1791_CR30","doi-asserted-by":"publisher","first-page":"e2202416","DOI":"10.1002\/advs202202416","volume":"10","author":"Q Ma","year":"2023","unstructured":"Ma Q, Wu S, Yang L, Wei Y, He C, Wang W, et al. Hyaluronic acid-guided cerasome nano-agents for simultaneous imaging and treatment of advanced atherosclerosis. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2023;10:e2202416. https:\/\/doi.org\/10.1002\/advs202202416.","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"1791_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s12951-023-02228-z","volume":"21","author":"J Tang","year":"2023","unstructured":"Tang J, Li T, Xiong X, Yang Q, Su Z, Zheng M, et al. Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of NF-\u03baB\/NLRP3 pathways in inflammatory endothelial cells. J Nanobiotechnol. 2023;21:460. https:\/\/doi.org\/10.1186\/s12951-023-02228-z.","journal-title":"J Nanobiotechnol"},{"key":"1791_CR32","doi-asserted-by":"publisher","first-page":"155274","DOI":"10.1016\/j.metabol.2022.155274","volume":"135","author":"X Jia","year":"2022","unstructured":"Jia X, Bai X, Yang X, Wang L, Lu Y, Zhu L, et al. VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis. Metab Clin Exp. 2022;135: 155274. https:\/\/doi.org\/10.1016\/j.metabol.2022.155274.","journal-title":"Metab Clin Exp"},{"key":"1791_CR33","doi-asserted-by":"publisher","first-page":"10625","DOI":"10.1021\/acsnano4c00909","volume":"18","author":"M Zhan","year":"2024","unstructured":"Zhan M, Sun H, Wang Z, Li G, Yang R, Mignani S, et al. Nanoparticle-mediated multiple modulation of bone microenvironment to tackle osteoarthritis. ACS Nano. 2024;18:10625\u201341. https:\/\/doi.org\/10.1021\/acsnano4c00909.","journal-title":"ACS Nano"},{"key":"1791_CR34","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1016\/j.molcel.2021.08.018","volume":"81","author":"C Lennicke","year":"2021","unstructured":"Lennicke C, Cochem\u00e9 HM. Redox metabolism: ROS as specific molecular regulators of cell signaling and function. Mol Cell. 2021;81:3691\u2013707. https:\/\/doi.org\/10.1016\/j.molcel.2021.08.018.","journal-title":"Mol Cell"},{"key":"1791_CR35","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1038\/s41467-019-13114-4","volume":"10","author":"Z Su","year":"2019","unstructured":"Su Z, Burchfield JG, Yang P, Humphrey SJ, Yang G, Francis D, et al. Global redox proteome and phosphoproteome analysis reveals redox switch in Akt. Nat Commun. 2019;10:5486. https:\/\/doi.org\/10.1038\/s41467-019-13114-4.","journal-title":"Nat Commun"},{"key":"1791_CR36","doi-asserted-by":"publisher","first-page":"687394","DOI":"10.3389\/fphar.2021.687394","volume":"12","author":"X Liu","year":"2021","unstructured":"Liu X, Xu Y, Cheng S, Zhou X, Zhou F, He P, et al. Geniposide combined with notoginsenoside R1 attenuates inflammation and apoptosis in atherosclerosis via the AMPK\/mTOR\/Nrf2 signaling pathway. Front Pharmacol. 2021;12: 687394. https:\/\/doi.org\/10.3389\/fphar.2021.687394.","journal-title":"Front Pharmacol"},{"key":"1791_CR37","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.18632\/aging.103034","volume":"12","author":"W Bian","year":"2020","unstructured":"Bian W, Jing X, Yang Z, Shi Z, Chen R, Xu A, et al. Downregulation of LncRNA NORAD promotes Ox-LDL-induced vascular endothelial cell injury and atherosclerosis. Aging. 2020;12:6385\u2013400. https:\/\/doi.org\/10.18632\/aging.103034.","journal-title":"Aging"},{"key":"1791_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40659-021-00335-5","volume":"54","author":"X Zhang","year":"2021","unstructured":"Zhang X, Lu J, Zhang Q, Luo Q, Liu B. CircRNA RSF1 regulated ox-LDL induced vascular endothelial cells proliferation, apoptosis and inflammation through modulating miR-135b-5p\/HDAC1 axis in atherosclerosis. Biol Res. 2021;54:11. https:\/\/doi.org\/10.1186\/s40659-021-00335-5.","journal-title":"Biol Res"},{"key":"1791_CR39","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1039\/d1tb02000e","volume":"10","author":"S Liu","year":"2022","unstructured":"Liu S, Zhao Y, Shen M, Hao Y, Wu X, Yao Y, et al. Hyaluronic acid targeted and pH-responsive multifunctional nanoparticles for chemo-photothermal synergistic therapy of atherosclerosis. J Mater Chem B. 2022;10:562\u201370. https:\/\/doi.org\/10.1039\/d1tb02000e.","journal-title":"J Mater Chem B"},{"key":"1791_CR40","doi-asserted-by":"publisher","first-page":"10517","DOI":"10.1021\/acsnano2c01778","volume":"16","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Wang S, Liang X, Heger Z, Xu M, Lu Q, et al. Turning hot into cold: immune microenvironment reshaping for atherosclerosis attenuation based on pH-responsive shSiglec-1 delivery system. ACS Nano. 2022;16:10517\u201333. https:\/\/doi.org\/10.1021\/acsnano2c01778.","journal-title":"ACS Nano"},{"key":"1791_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413624","author":"T Rong","year":"2021","unstructured":"Rong T, Wei B, Ao M, Zhao H, Li Y, Zhang Y, et al. Enhanced anti-atherosclerotic efficacy of pH-Responsively releasable Ganglioside GM3 delivered by reconstituted high-density lipoprotein. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222413624.","journal-title":"Int J Mol Sci"},{"key":"1791_CR42","doi-asserted-by":"publisher","first-page":"102557","DOI":"10.1016\/j.nano.2022.102557","volume":"43","author":"G Li","year":"2022","unstructured":"Li G, Xu F, Yang B, Lu X, Li X, Qi Y, et al. A nanotherapy responsive to the inflammatory microenvironment for the dual-targeted treatment of atherosclerosis. Nanomedicine: Nanatechnol Biology Med. 2022;43:102557. https:\/\/doi.org\/10.1016\/j.nano.2022.102557.","journal-title":"Nanomedicine: Nanatechnol Biology Med"},{"key":"1791_CR43","doi-asserted-by":"publisher","first-page":"757926","DOI":"10.3389\/fcvm.2021.757926","volume":"8","author":"X Lin","year":"2021","unstructured":"Lin X, Sun Y, Yang S, Yu M, Pan L, Yang J, et al. Omentin-1 modulates macrophage function via integrin receptors \u03b1v\u03b23 and \u03b1v\u03b25 and reverses plaque vulnerability in animal models of atherosclerosis. Front Cardiovasc Med. 2021;8: 757926. https:\/\/doi.org\/10.3389\/fcvm.2021.757926.","journal-title":"Front Cardiovasc Med"},{"key":"1791_CR44","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/circresaha.115.306301","volume":"118","author":"MA Gimbrone Jr","year":"2016","unstructured":"Gimbrone MA Jr, Garc\u00eda-Carde\u00f1a G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circul Res. 2016;118:620\u201336. https:\/\/doi.org\/10.1161\/circresaha.115.306301.","journal-title":"Circul Res"},{"key":"1791_CR45","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacological Reviews. 2021;73:924\u201367. https:\/\/doi.org\/10.1124\/pharmrev.120.000096.","journal-title":"Pharmacological Reviews"},{"key":"1791_CR46","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1161\/circresaha121319540","volume":"130","author":"M Jia","year":"2022","unstructured":"Jia M, Li Q, Guo J, Shi W, Zhu L, Huang Y, et al. Deletion of BACH1 attenuates atherosclerosis by reducing endothelial inflammation. Circul Res. 2022;130:1038\u201355. https:\/\/doi.org\/10.1161\/circresaha121319540.","journal-title":"Circul Res"},{"key":"1791_CR47","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/circresaha.116.309326","volume":"120","author":"U F\u00f6rstermann","year":"2017","unstructured":"F\u00f6rstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circul Res. 2017;120:713\u201335. https:\/\/doi.org\/10.1161\/circresaha.116.309326.","journal-title":"Circul Res"},{"key":"1791_CR48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/moh0000000000000573","volume":"27","author":"GE Hernandez","year":"2020","unstructured":"Hernandez GE, Iruela-Arispe ML. The many flavors of monocyte\/macrophage\u2013endothelial cell interactions. Curr Opin Hematol. 2020;27:181\u20139. https:\/\/doi.org\/10.1097\/moh0000000000000573.","journal-title":"Curr Opin Hematol"},{"key":"1791_CR49","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.yexcr.2013.03.026","volume":"319","author":"C Baer","year":"2013","unstructured":"Baer C, Squadrito ML, Iruela-Arispe ML, De Palma M. Reciprocal interactions between endothelial cells and macrophages in angiogenic vascular niches. Exp Cell Res. 2013;319:1626\u201334. https:\/\/doi.org\/10.1016\/j.yexcr.2013.03.026.","journal-title":"Exp Cell Res"},{"key":"1791_CR50","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/jlb.55.3.410","volume":"55","author":"C Sunderk\u00f6tter","year":"1994","unstructured":"Sunderk\u00f6tter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol. 1994;55:410\u201322. https:\/\/doi.org\/10.1002\/jlb.55.3.410.","journal-title":"J Leukoc Biol"},{"key":"1791_CR51","doi-asserted-by":"publisher","first-page":"031001","DOI":"10.1088\/1478-3975\/13\/3\/031001","volume":"13","author":"S Kaczanowski","year":"2016","unstructured":"Kaczanowski S. Apoptosis: its origin, history, maintenance and the medical implications for cancer and aging. Phys Biol. 2016;13: 031001. https:\/\/doi.org\/10.1088\/1478-3975\/13\/3\/031001.","journal-title":"Phys Biol"},{"key":"1791_CR52","doi-asserted-by":"publisher","first-page":"8709","DOI":"10.1039\/d1nr06514a","volume":"14","author":"N Cheraga","year":"2022","unstructured":"Cheraga N, Ye Z, Xu MJ, Zou L, Sun NC, Hang Y, et al. Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin. Nanoscale. 2022;14:8709\u201326. https:\/\/doi.org\/10.1039\/d1nr06514a.","journal-title":"Nanoscale"},{"key":"1791_CR53","doi-asserted-by":"publisher","first-page":"14946","DOI":"10.1021\/acsami0c01786","volume":"12","author":"M Gisbert-Garzar\u00e1n","year":"2020","unstructured":"Gisbert-Garzar\u00e1n M, Berkmann JC, Giasafaki D, Lozano D, Spyrou K, Manzano M, et al. Engineered pH-responsive mesoporous carbon nanoparticles for drug delivery. ACS Appl Mater Interfaces. 2020;12:14946\u201357. https:\/\/doi.org\/10.1021\/acsami0c01786.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1791_CR54","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1039\/c7cs00399d","volume":"47","author":"H Wang","year":"2018","unstructured":"Wang H, Chen Q, Zhou S. Carbon-based hybrid nanogels: a synergistic nanoplatform for combined biosensing, bioimaging, and responsive drug delivery. Chem Soc Rev. 2018;47:4198\u2013232. https:\/\/doi.org\/10.1039\/c7cs00399d.","journal-title":"Chem Soc Rev"},{"issue":"Suppl E","key":"1791_CR55","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1016\/s0195-668x(97)90005-1","volume":"18","author":"PM Vanhoutte","year":"1997","unstructured":"Vanhoutte PM. Endothelial dysfunction and atherosclerosis. Eur Heart J. 1997;18(Suppl E):E19\u201329. https:\/\/doi.org\/10.1016\/s0195-668x(97)90005-1.","journal-title":"Eur Heart J"},{"key":"1791_CR56","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.7150\/thno70896","volume":"12","author":"F Fang","year":"2022","unstructured":"Fang F, Ni Y, Yu H, Yin H, Yang F, Li C, et al. Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against atherosclerosis. Theranostics. 2022;12:4200\u201320. https:\/\/doi.org\/10.7150\/thno70896.","journal-title":"Theranostics"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01791-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01791-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01791-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:45:20Z","timestamp":1751388320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01791-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1791"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01791-2","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"6 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The surgical methods and experimental protocols were approved by the Animal Experimentation Committee of Southwestern Medical University (approval number swmu20220112) prior to performing animal experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed with publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}